Financial reports
10-K
2023 FY
Annual report
15 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
16 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
18 Feb 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
Current reports
8-K
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
15 Feb 24
8-K
Departure of Directors or Certain Officers
16 Jan 24
8-K
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
8 Jan 24
8-K
10x Genomics Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K
10x Genomics Reports Second Quarter 2023 Financial Results
3 Aug 23
8-K
Departure of Directors or Certain Officers
20 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Other Events
17 May 23
8-K
10x Genomics Reports First Quarter 2023 Financial Results
3 May 23
8-K
10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023
15 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
15 Feb 24
S-8
Registration of securities for employees
16 Feb 23
S-8
Registration of securities for employees
18 Feb 22
S-8
Registration of securities for employees
1 Mar 21
S-3ASR
Automatic shelf registration
16 Oct 20
424B4
Prospectus supplement with pricing info
11 Sep 20
S-1MEF
Registration of additional securities for an S-1
10 Sep 20
S-1
IPO registration
8 Sep 20
DRS
Draft registration statement
21 Aug 20
424B3
Prospectus supplement
26 Sep 19
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
Other
EFFECT
Notice of effectiveness
11 Sep 20
CORRESP
Correspondence with SEC
8 Sep 20
UPLOAD
Letter from SEC
25 Aug 20
EFFECT
Notice of effectiveness
12 Sep 19
CORRESP
Correspondence with SEC
11 Sep 19
CORRESP
Correspondence with SEC
10 Sep 19
CERT
Certification of approval for exchange listing
6 Sep 19
UPLOAD
Letter from SEC
6 Sep 19
SEC STAFF
SEC staff action: Order
3 Sep 19
UPLOAD
Letter from SEC
29 Aug 19
Ownership
4
Serge Saxonov
25 Mar 24
4
Benjamin J. Hindson
25 Mar 24
4
Justin J. McAnear
25 Mar 24
4
Serge Saxonov
18 Mar 24
4
Serge Saxonov
6 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
4
Serge Saxonov
26 Feb 24
4
Benjamin J. Hindson
26 Feb 24
4
Justin J. McAnear
26 Feb 24
144
Notice of proposed sale of securities
22 Feb 24